Researcher receives $1.25M grant to examine a novel drug’s ability to improve radiation therapy in mice for brain cancer
Research supporting potential of new drug to radiosensitize glioblastoma multiforme cancer cells published in Molecular Cancer Therapeutics A leading researcher at Virginia Commonwealth University Massey Cancer Center received a five-year, $1.25 million grant from the National Cancer Institute to study … Continue reading